EI
BMY icon

EDMP Inc’s Bristol-Myers Squibb BMY Stock Holding History

EDMP Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.06M Sell
35,784
-126
-0.4% -$7.24K 1.66% 22
2026
Q1 		$2.18M Sell
35,910
-96
-0.3% -$5.6K 1.76% 21
2025
Q4 		$1.94M Sell
36,006
-1,825
-5% -$87.8K 1.6% 21
2025
Q3 		$1.71M Buy
37,831
+152
+0.4% +$7.1K 1.35% 31
2025
Q2 		$1.74M Sell
37,679
-2,094
-5% -$103K 1.48% 24
2025
Q1 		$2.43M Sell
39,773
-1,826
-4% -$106K 2.03% 17
2024
Q4 		$2.35M Buy
41,599
+171
+0.4% +$9.55K 2.23% 14
2024
Q3 		$2.14M Buy
41,428
+238
+0.6% +$11.2K 1.76% 20
2024
Q2 		$1.71M Sell
41,190
-2,143
-5% -$95.9K 1.55% 23
2024
Q1 		$2.35M Buy
43,333
+59
+0.1% +$3.01K 1.96% 18
2023
Q4 		$2.22M Buy
43,274
+740
+2% +$38.8K 2.02% 17
2023
Q3 		$2.47M Sell
42,534
-2,861
-6% -$175K 2.52% 12
2023
Q2 		$2.9M Sell
45,395
-198
-0.4% -$13.3K 2.76% 11
2023
Q1 		$3.16M Sell
45,593
-878
-2% -$61.9K 3.16% 10
2022
Q4 		$3.34M Sell
46,471
-1,402
-3% -$106K 3.29% 11
2022
Q3 		$3.4M Buy
47,873
+47
+0.1% +$3.41K 3.63% 8
2022
Q2 		$3.68M Buy
47,826
+1,719
+4% +$131K 3.6% 8
2022
Q1 		$3.37M Buy
46,107
+6,044
+15% +$406K 3.16% 11
2021
Q4 		$2.5M Sell
40,063
-1,137
-3% -$66.7K 2.48% 16
2021
Q3 		$2.46M Buy
41,200
+1,422
+4% +$93.6K 2.6% 17
2021
Q2 		$2.66M Buy
39,778
+555
+1% +$36.2K 2.79% 13
2021
Q1 		$2.48M Buy
39,223
+24,072
+159% +$1.5M 2.62% 14
2020
Q4 		$940K Sell
15,151
-109
-0.7% -$6.7K 1.28% 29
2020
Q3 		$920K Sell
15,260
-53
-0.3% -$3.19K 1.35% 29
2020
Q2 		$900K Buy
+15,313
New +$916K 1.4% 27

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

EDMP Inc's BMY Position: Q2 2026 in Review

EDMP Inc reduced its Bristol-Myers Squibb (BMY) stake by 0.35% in Q2 2026, selling an estimated $7.24K and leaving 35,784 shares worth $2.06M. The position accounts for 1.66% of the portfolio, ranked #22.

EDMP Inc first reported a position in BMY in Q2 2020 and has held it in 25 quarters since. The position peaked at $3.68M in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • EDMP Inc held 35,784 shares of Bristol-Myers Squibb worth $2.06M as of Q2 2026.
  • EDMP Inc sold 126 Bristol-Myers Squibb shares in Q2 2026, an estimated $7.24K.
  • Bristol-Myers Squibb made up 1.66% of EDMP Inc's portfolio in Q2 2026, its #22 holding.
  • EDMP Inc first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 25 quarters since.
  • EDMP Inc's Bristol-Myers Squibb position peaked at $3.68M in Q2 2022.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on EDMP Inc's 13F filing for Q2 2026, filed 29 Jul 2026.